AFB-detection by smear examination ZN Stain Urine, 1 samples
Unit Test
Report in 36Hrs
At Home
No Fasting Required
Details
Primarily used to evaluate urinary tuberculosis (genitourinary TB)
₹149₹500
70% OFF
AFB-detection by smear examination ZN Stain Urine 1 samples
AFB-detection by smear examination ZN Stain Urine 1 samples
Why is it done?
Detects acid-fast bacilli (AFB) in urine samples, primarily to diagnose tuberculosis (TB), particularly extrapulmonary TB affecting the urogenital system
Used to identify Mycobacterium tuberculosis in urine specimens, which indicates renal or urogenital tuberculosis infection
Typically performed when patients present with symptoms such as dysuria, hematuria, pyuria without bacterial growth, or chronic urinary complaints suggestive of TB
Essential in TB surveillance and diagnosis programs as part of diagnostic confirmation and treatment monitoring protocols
Recommended for patients with known pulmonary TB to rule out disseminated disease, and for suspected cases of genitourinary TB
Normal Range
Negative Result: Reported as 'AFB Not Seen' or 'Negative for AFB' - indicates absence of acid-fast bacilli in the urine specimen
Positive Result: Reported as 'AFB Seen' or 'Positive for AFB' - indicates presence of acid-fast bacilli, consistent with mycobacterial infection
Quantification: Positive results may be graded as 1+, 2+, 3+, or scanty based on the number of AFB observed per microscopic field
Units: Qualitative assessment per microscopic field under Ziehl-Neelsen staining
Interpretation
Negative AFB Smear: Suggests absence of mycobacterial infection in the urinary tract. However, a single negative result does not completely rule out TB, as AFB may not be present in all specimens from infected individuals.
Positive AFB Smear (Scanty/1+): Indicates low bacillary load; highly suggestive of mycobacterial infection. Further confirmation with culture or PCR recommended.
Positive AFB Smear (2+/3+): Indicates moderate to high bacillary load, strongly confirmatory for active mycobacterial infection. Patient is typically considered infectious.
Factors Affecting Results: Sample collection timing (morning urine preferred as it is more concentrated), adequate sample volume (24-hour collection may increase sensitivity), specimen handling, and patient immune status
Clinical Significance: Positive results confirm genitourinary TB diagnosis. Smear positivity correlates with infectiousness and treatment responsiveness, making it crucial for public health monitoring.
Associated Organs
Primary Organ Systems: Urinary system (kidneys, ureters, bladder, urethra) and reproductive system (prostate, seminal vesicles, fallopian tubes, ovaries)
Complications and Risks: Renal scarring and fibrosis, chronic kidney disease, ureteric strictures, bladder contracture, infertility, sepsis, disseminated TB if untreated
Related Pathophysiology: Mycobacterium tuberculosis reaches the urinary tract through hematogenous dissemination from primary TB focus, causing granulomatous inflammation and tissue destruction
Follow-up Tests
Culture and Sensitivity: Gold standard for TB diagnosis; urine cultures on Lowenstein-Jensen or MGIT media for definitive identification and drug susceptibility testing
GeneXpert MTB/RIF (Xpert MTB/RIF): WHO-endorsed rapid molecular test for TB diagnosis and rifampicin resistance detection on urine samples
PCR Testing: Polymerase chain reaction for MTB DNA amplification; high sensitivity and specificity for confirming TB infection
Imaging Studies: CT scan or ultrasound of abdomen/pelvis to assess extent of renal and urogenital TB damage and guide treatment
Urinalysis: Complete urinalysis to assess pyuria, hematuria, and other abnormalities; sterile pyuria is typical of renal TB
Renal Function Tests: Creatinine, BUN, and eGFR to monitor kidney function; repeated at baseline and during treatment
Chest X-Ray: To detect concurrent pulmonary TB; genitourinary TB often occurs with pulmonary involvement
Monitoring During Treatment: Repeat AFB smear examination monthly during first 2 months, then bimonthly; should show decreasing AFB grades with effective treatment
Fasting Required?
Fasting: No - Fasting is NOT required for this test
Sample Collection Instructions: Morning urine specimen preferred (early morning first void) as it is more concentrated and has higher yield of AFB. Collect 24-hour or early morning urine sample as per laboratory protocol.
Special Preparation: No special fasting or dietary restrictions. Patient may eat and drink normally. Ensure proper genital/perineal hygiene before sample collection to avoid contamination.
Medications: Continue all regular medications as scheduled. No specific medications need to be withheld for this test.
Sample Handling: Use sterile, wide-mouthed container. Process samples within 2-4 hours of collection for optimal sensitivity. Refrigerate if delayed processing is anticipated.
Timing of Test: Can be performed at any time of day, but morning urine is preferred. Multiple samples on consecutive days may increase diagnostic sensitivity.